The plasma levels of the 71 patients that experienced MACE showed a significant increase in three specific ceramides (d18:1/16:0, d18:1/22:0 and d18:1/24:0), all of which were highly significant in predicting MACE.
← all excerpts
The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers.
1
—
—